CRAIN ELIZABETH 4

What Happened

• Elizabeth Crain, a director of Core Scientific, was awarded 18,575 restricted stock units (RSUs) on February 4, 2026. The Form 4 shows the acquisition price as $0.00 (grant of awards), so no cash was exchanged at the time of grant.

Key Details

• Transaction date: 2026-02-04; Transaction code: A (award/grant).
• Shares/units granted: 18,575 RSUs; reported acquisition price: $0.00 (grant).
• Vesting: RSUs will vest in full on February 3, 2027, provided Ms. Crain remains a non‑employee director on that date (see footnote).
• Shares owned after transaction: not specified in the supplied summary of the filing.
• Filing timeliness: Report filed 2026-02-06 for a 2026-02-04 transaction (appears timely under Form 4 rules).

Context

• RSUs are a form of deferred compensation that convert to shares only if vesting conditions are met; they are not immediate purchases or sales and do not indicate an immediate market transaction. Director RSU grants are common as part of board compensation and should be interpreted as compensation rather than a direct bullish or bearish trade signal.